Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy

NCT03205033 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Sleep Disorders, Circadian Rhythm
Depression
Genotoxicity
Pain

Interventions

DRUG: Melatonin 20 MG Oral Capsule
DRUG: Placebo oral capsule

Sponsor

Hospital de Clinicas de Porto Alegre